Masayoshi Yamaguchi

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Bone Health Research. Top assignees: Primus Pharmaceuticals, Inc., Maruhachi Muramatsu, Inc., Toshiba Teli Corporation. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayoshi Yamaguchi. Retrieved from https://idiyas.com/inventor/masayoshi-yamaguchi-njax145k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 71.4

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 21(Granted Patents)

Location History:

Joetsu, JP (2013)
Shizuoka, JP (1994 - 2019)

Company Filing History:

3 out of 12

Primus Pharmaceuticals, Inc.

patents

2 out of 3

Maruhachi Muramatsu, Inc.

patents

2 out of 5

Toshiba Teli Corporation

Hamari Chemicals Co., Ltd.

patent

6. 1 out of 1,329

Japan Science and Technology Agency

Meiji Seika Kaisha, Ltd.

patents

9. 1 out of 4

Taishi Foods Company Ltd.

patents

10. 1 out of 45

Zeria Pharmaceutical Co., Ltd.

patents

11. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2026

Loading Chart...

Areas of Expertise:

Emollient Compositions

Linoleic Acid

Bone Health

Therapeutic Combinations

Cancer Cells

NF-kB Activation

Osteogenesis Promoter

Flavonoids

Sesquiterpenes

Industrial Imaging Camera

Inflammatory Conditions

Food Compositions

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661332 - Emollient compositions comprising linoleic acid and conjugated linoleic acid and methods of use (2026-06-23),

2. 10463705 - Method for treating disease associated with transcription activation by NF-κB (2019-11-05),

3. 10456365 - Methods and formulations for supporting and promoting bone health (2019-10-29),

4. 10300040 - Therapeutic combinations of sesquiterpenes and flavonoids (2019-05-28),

5. 10039740 - Therapeutic combinations of sesquiterpenes and flavonoids (2018-08-07),

6. 9937216 - Method for suppressing proliferation and/or inducing apoptosis of cancer cells (2018-04-10),

7. 9301945 - Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation (2016-04-05),

8. 8605207 - Small industrial electronic imaging camera provided with external interface cable (2013-12-10),

9. 8520136 - Small industrial electronic imaging camera (2013-08-27),

10. 8148431 - Osteogenesis promoter containing β-cryptoxanthin as the active ingredient (2012-04-03),

11. 7355093 - Model animal with overexpression of regucalcin (2008-04-08),

12. 6806252 - Bone-strengthening agents, food compositions for strengthening bone and feed compositions for strengthening (2004-10-19),

13. 5935996 - Composition for stimulating osteogenesis and preventingreduction of bone (1999-08-10),

14. 5294634 - Osteogenesis promoter (1994-03-15),

Title: Unveiling the Innovations of Masayoshi Yamaguchi

Introduction: Masayoshi Yamaguchi, a prolific inventor hailing from Shizuoka, Japan, has made a notable mark in the realm of patents with a total of 11 patents to his name. His groundbreaking inventions showcase his commitment to advancing healthcare and pharmaceuticals through innovative solutions.

Latest Patents: Among his latest patents is a revolutionary method for treating diseases associated with transcription activation by NF-κB. This method involves administering a composition aimed at inhibiting transcription activation by NF-κB to individuals in need of treatment. Additionally, Yamaguchi has also developed pharmaceutical formulations utilizing β-Caryophyllene to support and promote bone health.

Career Highlights: Throughout his career, Masayoshi Yamaguchi has demonstrated his expertise and dedication at companies such as Maruhachi Muramatsu, Inc. and Primus Pharmaceuticals, Inc. His leadership and innovative mindset have been instrumental in driving these companies towards success in the healthcare and pharmaceutical industries.

Collaborations: Noteworthy collaborations have been a cornerstone of Yamaguchi's inventive journey. One of his valued colleagues is M Neale Weitzmann, with whom he has worked closely on various projects, further enhancing the impact and reach of his innovative solutions.

Conclusion: Masayoshi Yamaguchi's relentless pursuit of innovation and his commitment to improving healthcare through patented inventions exemplify his significant contributions to the field. His pioneering spirit continues to inspire advancements in the realm of pharmaceuticals and beyond, leaving a lasting legacy in the world of inventions.

Profile summary based on public USPTO records.